CoChat

Novel Docosatrienes and 17S-Resolvins Generated from Docosahexaenoic Acid in Murine Brain, Human Blood, and Glial Cells

Open access

The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.

Abstract

Docosahexaenoic acid (DHA, C22:6) is highly enriched in brain, synapses, and retina and is a major omega-3 fatty acid. Deficiencies in this essential fatty acid are reportedly associated with neuronal function, cancer, and inflammation. Here, using new lipidomic analyses employing high performance liquid chromatography coupled with a photodiode-array detector and a tandem mass spectrometer, a novel series of endogenous mediators was identified in blood, leukocytes, brain, and glial cells as 17S-hydroxy-containing docosanoids denoted as docosatrienes (the main bioactive member of the series was 10,17S-docosatriene) and 17S series resolvins. These novel mediators were biosynthesized via epoxide-containing intermediates and proved potent (pico- to nanomolar range) regulators of both leukocytes reducing infiltration in vivo and glial cells blocking their cytokine production. These results indicate that DHA is the precursor to potent protective mediators generated via enzymatic oxygenations to novel docosatrienes and 17S series resolvins that each regulate events of interest in inflammation and resolution.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1074/jbc.m300218200

Cites

53 of 53 references verified0 citation errors · 0 not checkable

Statistics

Figures

Image 1
CC-BY · From the PDF
Image 2
CC-BY · From the PDF
Image 3
CC-BY · From the PDF
Image 4
CC-BY · From the PDF
Image 5
CC-BY · From the PDF
Image 6
CC-BY · From the PDF
FIG. 3 Human glial cells release and transform DHA. A , human glial cells were labeled with [1- 14 C]DHA and exposed to either PBS alone, zymosan A, or calcium ionophore (see 'Experimental Procedures'). Released [114 C]docosanoids were quantified ( n = 4). The asterisk denotes significant differences from control (PBS alone), p < 0.05 analysis of variance, Newman-Keuls test. The inset shows a representative HPLC radiochromatogram of released [1- 14 C]docosanoids (see 'Experimental Procedures') from glial cells exposed to zymosan A ( n = 3). Phospholipids from glial cells were identified, and the 14 C content in phosphatidylethanolamine ( PE ) was determined. The percent loss in PE 14 C content from cells exposed to agonists was determined ( n = 2). B , lipidomic profile of human glial cells exposed to Ca 2 + ionophore: LC-MS total ion chromatogram of released products. C , LC-MS selective ion chromatogram of released DHA-derived products from glial cells exposed to calcium ionophore. MS-MS and UV spectra of 𝛚 -22hydroxy-4 S ,17 S -diHDHA.
FIG. 3 Human glial cells release and transform DHA. A , human glial cells were labeled with [1- 14 C]DHA and exposed to either PBS alone, zymosan A, or calcium ionophore (see 'Experimental Procedures'). Released [114 C]docosanoids were quantified ( n = 4). The asterisk denotes significant differences from control (PBS alone), p < 0.05 analysis of variance, Newman-Keuls test. The inset shows a representative HPLC radiochromatogram of released [1- 14 C]docosanoids (see 'Experimental Procedures') from glial cells exposed to zymosan A ( n = 3). Phospholipids from glial cells were identified, and the 14 C content in phosphatidylethanolamine ( PE ) was determined. The percent loss in PE 14 C content from cells exposed to agonists was determined ( n = 2). B , lipidomic profile of human glial cells exposed to Ca 2 + ionophore: LC-MS total ion chromatogram of released products. C , LC-MS selective ion chromatogram of released DHA-derived products from glial cells exposed to calcium ionophore. MS-MS and UV spectra of 𝛚 -22hydroxy-4 S ,17 S -diHDHA.CC-BY · From the PDF
Image 8
CC-BY · From the PDF
FIG. 4 Glial cells generate 17 S series resolvins and 10,17 S -docosatriene. Human glial cells were exposed to DHA and calcium ionophore (37 °C, 30 min). The docosanoids were identified by LC-PDAMS-MS analysis. A , LC-MS-selective ion chromatograms showing generation of specific mono-HDHAs ( right ) and di-HDHAs ( left ). B , MS-MS of 𝛚 -22-hydroxy-16,17 S -docosatriene.
FIG. 4 Glial cells generate 17 S series resolvins and 10,17 S -docosatriene. Human glial cells were exposed to DHA and calcium ionophore (37 °C, 30 min). The docosanoids were identified by LC-PDAMS-MS analysis. A , LC-MS-selective ion chromatograms showing generation of specific mono-HDHAs ( right ) and di-HDHAs ( left ). B , MS-MS of 𝛚 -22-hydroxy-16,17 S -docosatriene.CC-BY · From the PDF
Image 10
CC-BY · From the PDF
FIG. 5 Substrate competition at human recombinant COX-2. Human rCOX-2 microsomal membranes from Sf9 cells were incubated with [1- 14 C]DHA (C22:6, 10 𝛍 M) in the presence of increasing concentrations of unlabeled arachidonic acid (C20:4). COX-2 conversion of [1- 14 C]DHA and specific product profiles were quantitated ( n = 3). rCOX-2 activity is expressed as the inhibition of [ 14 C]C22:6 product formation (95 ± 0.5%; conversion of DHA was set to 100%).
FIG. 5 Substrate competition at human recombinant COX-2. Human rCOX-2 microsomal membranes from Sf9 cells were incubated with [1- 14 C]DHA (C22:6, 10 𝛍 M) in the presence of increasing concentrations of unlabeled arachidonic acid (C20:4). COX-2 conversion of [1- 14 C]DHA and specific product profiles were quantitated ( n = 3). rCOX-2 activity is expressed as the inhibition of [ 14 C]C22:6 product formation (95 ± 0.5%; conversion of DHA was set to 100%).CC-BY · From the PDF
Image 12
CC-BY · From the PDF
Image 13
CC-BY · From the PDF
Image 14
CC-BY · From the PDF
Image 15
CC-BY · From the PDF
FIG. 8 Biosynthetic scheme proposed for 10,17 S -docosatrienes and 17 S series resolvins. These transformations may involve novel enzymes in addition to those that serve in the biosynthesis of eicosanoids (see text for further detail). The complete stereochemistry for the docosatrienes ( A ) and 17 S series resolvins ( B ) remain to be established and are depicted in their tentative configurations based on biogenic total synthesis, lipidomic analyses, and alcohol trapping profiles. The carbonium cation intermediate shown in A is also likely to be the enzymatic basis of the epoxide conversion in B .
FIG. 8 Biosynthetic scheme proposed for 10,17 S -docosatrienes and 17 S series resolvins. These transformations may involve novel enzymes in addition to those that serve in the biosynthesis of eicosanoids (see text for further detail). The complete stereochemistry for the docosatrienes ( A ) and 17 S series resolvins ( B ) remain to be established and are depicted in their tentative configurations based on biogenic total synthesis, lipidomic analyses, and alcohol trapping profiles. The carbonium cation intermediate shown in A is also likely to be the enzymatic basis of the epoxide conversion in B .CC-BY · From the PDF

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 53 references

Research works printed but not linked: 8

  1. Gallin, J. I., and Snyderman, R. (eds) (1999) Inflammation: Basic Principles and Clinical Correlates, Lippincott Williams & Wilkins, Philadelphia
  2. Bergstro ¨m, S. (1982) in Les Prix Nobel: Nobel Prizes, Presentations, Biogra- phies and Lectures, pp. 129 -148, Almqvist & Wiksell, Stockholm
  3. De Caterina, R., Endres, S., Kristensen, S. D., and Schmidt, E. B. (eds) (1993) n-3 Fatty Acids and Vascular Disease, Springer-Verlag, London
  4. Gronert, K., Clish, C. B., Romano, M., and Serhan, C. N. (1999) in Eicosanoid Protocols (Lianos, E. A., ed) pp. 119 -144, Humana Press, Totowa, NJ 28.
  5. Gronert, K., Colgan, S. P., and Serhan, C. N. (1998) J. Pharmacol. Exp. Ther. 285, 252-261
  6. Whelan, J., Reddanna, P., Nikolaev, V., Hildenbrandt, G. R., and Reddy, T. S. (1990) in Biological Oxidation Systems Vol. 2, pp. 765-778, Academic Press
  7. Bazan, N. G. (1990) in Nutrition and the Brain (Wurtman, R. J., and Wurtman, J. J., eds) Vol. 8, pp. 1-22, Raven Press, New York
  8. Bazan, N. G., and Rodriguez de Turco, E. B. (2001) in Neuroprotection (Lo, E. H., and Marwoh, J., eds) pp. 195, Prominent Press

Cited by

Items 801–900 of 997

Metadata

Authors
Hong, S., Gronert, K., Devchand, P. R., Moussignac, R.-L., & Serhan, C. N.
Affiliations
Brigham and Women's Hospital (US)
Corresponding author
Serhan, Charles N.
Venue
Journal of Biological Chemistry
Publisher
Elsevier BV
Published
2003-04
Volume
278
Issue
17
Pages
14677-14687
ISSN
0021-9258 (ISSN-L)
OpenAlex
W2082649626
Cited by
1,000
References
53
Citations by year
2026: 15 · 2025: 21 · 2024: 24 · 2023: 32 · 2022: 24 · 2021: 42 · 2020: 36 · 2019: 51 · 2018: 44 · 2017: 43 · 2016: 40 · 2015: 59 · 2014: 66 · 2013: 63 · 2012: 48
FWCI
34.30
Type
journal article
Language
en
Open access
Licence
Locations
  • Journal of Biological Chemistry (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
Funders
  • National Institute of General Medical Sciences (GM 38765)
  • National Institute of Diabetes and Digestive and Kidney Diseases (DK60583, K01DK060583)
  • National Institute of Dental and Craniofacial Research (P01 DE 13499, P01DE013499)
Topics
  • Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Eicosanoids and Hypertension Pharmacology
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Sphingolipid Metabolism and Signaling
Keywords
docosahexaenoic acid, docosanoids, omega-3 fatty acids, leukocyte infiltration, glial cells, cytokine production, inflammation resolution, epoxide intermediate, lipidomics, brain, leukocytes, leukotriene biosynthesis
MeSH terms
Animals, Blood, Brain, Chemotaxis, Leukocyte, Chromatography, High Pressure Liquid, Docosahexaenoic Acids, Fatty Acids, Unsaturated, Humans, Inflammation, Leukocytes, Neuroglia, Mass Spectrometry, Tumor Necrosis Factor-alpha, Cytokines, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.